TALICIA
Peakomeprazole magnesium, amoxicillin and rifabutin
NDAORALCAPSULE, DELAYED RELEASEPriority Review
Approved
Nov 2019
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Pharmacologic Class:
Rifamycin Antimycobacterial
Loss of Exclusivity
LOE Date
May 27, 2042
197 months away
Patent Expiry
May 27, 2042
Exclusivity Expiry
Nov 1, 2027